NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19

LOS ANGELES, Feb. 15 (Xinhua) -- The U.S. National Institutes of Health (NIH) has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19, the agency announced on Wednesday. Read full story

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

The National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.

NIH to Study Shionogi’s Covid Antiviral in Hospitalized Patients

US researchers have begun a final-stage study of Shionogi & Co.’s Xocova antiviral in hospitalized Covid-19 patients to see whether it can help improve care as the number of available therapies diminishes.

The United States starts a trial to evaluate antivirals in adults hospitalized with Covid

The United States starts a trial to evaluate antivirals in adults hospitalized with Covid

U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19--China Economic Net

U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19 - People's Daily Online

A man wearing a face mask is seen on a street in Washington, D.C., the United States, on Dec. 1